LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

Search

Odonate Therapeutics Inc

Închisă

0

Rezumat

Modificarea prețului

24h

Curent

Minim

Maxim

Indicatori cheie

By Trading Economics

Odonate Therapeutics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

5 mar. 2026, 23:01 UTC

Câștiguri

Costco Evaluating Possibility of Tariff Refunds as 2Q Revenue Rises - Update

5 mar. 2026, 21:54 UTC

Câștiguri

Costco Posts Higher 2Q Profit on Rising Sales, Membership Fees

5 mar. 2026, 21:35 UTC

Principalele dinamici ale pieței

ServiceNow Shares Rise After CEO Says AI Can Add Value to Software

6 mar. 2026, 00:00 UTC

Evenimente importante

Its Missile Threat Degraded, Iran Is Taking Fewer Shots at More Targets -- WSJ

5 mar. 2026, 23:46 UTC

Market Talk

Nikkei May Decline Amid Concerns About Energy Costs -- Market Talk

5 mar. 2026, 23:33 UTC

Market Talk

Gold Edges Higher on Possible Technical Recovery -- Market Talk

5 mar. 2026, 23:27 UTC

Market Talk

Middle East Fighting Will Prompt RBA to Delay Hike -- Market Talk

5 mar. 2026, 22:54 UTC

Market Talk
Câștiguri

Costco Sold a $150,000 Diamond Ring in 2Q -- Market Talk

5 mar. 2026, 22:50 UTC

Market Talk

Woodside Has More Exposure to Rising Gas Prices Than Santos -- Market Talk

5 mar. 2026, 22:48 UTC

Câștiguri

Nike Reports $300 Million Pretax Charge Related to Job Cuts -- Barrons.com

5 mar. 2026, 22:46 UTC

Câștiguri

Costco Evaluating Possibility of Tariff Refunds as 2Q Revenue Rises -- Update

5 mar. 2026, 22:44 UTC

Câștiguri

Costco Earnings Beat Expectations as Membership Model Shines -- Barrons.com

5 mar. 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

5 mar. 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

5 mar. 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

5 mar. 2026, 21:35 UTC

Câștiguri

Marvell Earnings Beat Estimates on 'Robust' AI Demand. The Stock Jumps. -- Barrons.com

5 mar. 2026, 21:32 UTC

Câștiguri

Costco Earnings Beat Expectations as Membership Model Shines -- Barrons.com

5 mar. 2026, 21:26 UTC

Câștiguri

These Stocks Are Today's Movers: Broadcom, Trade Desk, Berkshire Hathaway, Rigetti, Corning, Ciena, Expedia, and More -- Barrons.com

5 mar. 2026, 21:24 UTC

Câștiguri

Costco February Digitally-Enabled Sales Ex-Changes in Gas and Foreign Exchange Rose 20.8% >COST

5 mar. 2026, 21:23 UTC

Câștiguri

Costco February Same-Store Sales Ex-Changes in Gas and Foreign Exchange Rose 7% >COST

5 mar. 2026, 21:22 UTC

Câștiguri

Costco 2Q Same-Store Sales Ex-Changes in Gas and Foreign Rose 6.7% >COST

5 mar. 2026, 21:21 UTC

Câștiguri

Costco February Digitally-Enabled Sales Rose 21.8% >COST

5 mar. 2026, 21:21 UTC

Câștiguri

Costco Total Co Comparable Sales for February Rose 7.9% >COST

5 mar. 2026, 21:20 UTC

Câștiguri

Costco February Net Sales Were $21.69 B >COST

5 mar. 2026, 21:20 UTC

Câștiguri

Marvell Earnings Beat Estimates on 'Robust' AI Demand. The Stock Jumps. -- Barrons.com

5 mar. 2026, 21:20 UTC

Câștiguri

Costco Same-Store Sales Ex-Changes in Gas and Foreign Rose 6.7% >COST

5 mar. 2026, 21:19 UTC

Câștiguri

Costco 2Q Digitally-Enabled Sales Ex-Changes in Gas and Foreign Exchange Rose 21.7% >COST

5 mar. 2026, 21:18 UTC

Câștiguri

Costco 2Q Digitally-Enabled Sales Rose 22.6% >COST

5 mar. 2026, 21:18 UTC

Câștiguri

Costco 2Q Same-Store Sales Up 7.4% >COST

5 mar. 2026, 21:15 UTC

Câștiguri

Costco 2Q EPS $4.58 >COST

Comparație

Modificare preț

Odonate Therapeutics Inc Așteptări

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

EBITDA

Profit operațional

$

Despre Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.
help-icon Live chat